Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87M
-
Number of holders
-
183
-
Total 13F shares, excl. options
-
80.5M
-
Shares change
-
+1.59M
-
Total reported value, excl. options
-
$531M
-
Value change
-
-$1.74M
-
Put/Call ratio
-
1.15
-
Number of buys
-
94
-
Number of sells
-
-91
-
Price
-
$6.60
Significant Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q1 2025
223 filings reported holding KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share as of Q1 2025.
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) has 183 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 80.5M shares
of 87M outstanding shares and own 92.51% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (8.18M shares), BVF INC/IL (7.75M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (7.44M shares), ARMISTICE CAPITAL, LLC (6.57M shares), VANGUARD GROUP INC (4.95M shares), RA CAPITAL MANAGEMENT, L.P. (4M shares), STATE STREET CORP (3.28M shares), EcoR1 Capital, LLC (2.64M shares), Prosight Management, LP (2.08M shares), and MORGAN STANLEY (1.92M shares).
This table shows the top 183 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.